Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O6YE
|
|||
| Former ID |
DNCL003706
|
|||
| Drug Name |
RG7450
|
|||
| Synonyms |
Anti-STEAP1, DSTP3086S
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1 | [1] | |
| Company |
Seattle Genetics; Roche
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Metalloreductase STEAP1 (STEAP1) | Target Info | Modulator | [2] |
| KEGG Pathway | Mineral absorption | |||
| WikiPathways | Copper homeostasis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033873) | |||
| REF 2 | Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development. Mar Drugs. 2014 January; 12(1): 255-278. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.